Whitehawk Therapeutics (WHWK) Shares Outstanding (Diluted Average) (2019 - 2025)

Whitehawk Therapeutics (WHWK) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $61.9 million in Q4 2025.

• Quarterly Shares Outstanding (Diluted Average) rose 128.96% year-over-year to $61.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $61.9 million (up 128.96% YoY) and the FY2025 annual result came in at $61.9 million, up 128.96% from the prior year.
• Shares Outstanding (Diluted Average) climbed to $61.9 million in Q4 2025 per WHWK's latest filing, from $39.9 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $61.9 million in Q4 2025 and bottomed at $2.5 million in Q2 2021.
• The 5-year median for Shares Outstanding (Diluted Average) is $26.9 million (2023), against an average of $24.9 million.
• The widest annual swing landed in 2021, when Shares Outstanding (Diluted Average) tumbled 93.78%; it then jumped 723.76% in 2022.
• Tracing WHWK's Shares Outstanding (Diluted Average) over 5 years: stood at $8.9 million in 2021, then jumped by 152.27% to $22.5 million in 2022, then grew by 19.58% to $26.9 million in 2023, then climbed by 0.42% to $27.0 million in 2024, then soared by 128.96% to $61.9 million in 2025.
• Per Business Quant, the three latest WHWK Shares Outstanding (Diluted Average) figures stand at $61.9 million (Q4 2025), $39.9 million (Q1 2025), and $27.0 million (Q4 2024).

Peer Comparison